Tatiana Itina | nanotechnology | Best Researcher Award

Published on by Chemical Scientist

Prof. Dr. Tatiana Itina | nanotechnology | Best Researcher Award

Research Director at CNRS, Lab. Hubert Curien UMR 5516/UJM, France.

Dr. Tatiana E. Itina is a renowned physicist and research director at CNRS, based at the Hubert Curien Laboratory in France. 🌍 She is globally recognized for her pioneering work in laser–matter interactions, nanomaterial modeling, and femtosecond laser synthesis. πŸ”¬ With over 130 publications and leadership in international projects, she founded the LASERMODE and PREDICT teams, contributing significantly to sustainable nanotechnology, photonics, and medical applications. πŸ’‘ Her theoretical frameworks and simulations have shaped modern approaches in nanoparticle formation and surface chemistry. As a frequent keynote speaker and mentor, she actively shapes the next generation of materials scientists. πŸ‘©β€πŸ”¬βœ¨

PROFILEΒ 

GOOGLE SCHOLAR

SCOPUSΒ 

ORCIDΒ 

πŸ” Summary of Suitability:

Dr. Tatiana E. Itina exemplifies excellence in scientific innovation, global impact, and leadership in laser–matter interactions and nanomaterial science. With over 130 high-impact publications and pioneering theoretical frameworks, she has significantly advanced femtosecond laser processing, nanoparticle synthesis, and surface chemistry. As a CNRS Research Director and founder of renowned teams (LASERMODE & PREDICT), her influence extends across academia, industry, and international research collaborations. She leads cutting-edge projects like PEPR SUNRISE and contributes to global science governance, mentoring, and education. Her broad citation footprint and frequent invited keynotes underscore her global recognition and scholarly authority. πŸŒπŸ“š

Education & ExperienceΒ  πŸ“˜

  • πŸ“˜ HDR (Habilitation): UniversitΓ© de la MΓ©diterranΓ©e, France – 2008

  • πŸŽ“ PhD in Physics: Aix-Marseille University & MIPT (cotutelle) – 1999

  • πŸ§‘β€πŸŽ“ MSc in Physics/Engineering: MIPT, Moscow Institute of Physics and Technology – 1994 (with honors)

  • πŸ‘©β€πŸ”¬ Director of Research, CNRS – 2010–present

  • πŸ§ͺ Team Leader, LASERMODE & PREDICT research groups

  • 🧭 Scientific Secretary, CNRS Section 10 (2021–2025)

Professional Development πŸš€πŸ“–

Dr. Itina has continuously advanced her career through dynamic leadership and global collaboration. 🀝 She leads strategic initiatives like PEPR SUNRISE and ANR LAMORSIM, focusing on ultrafast laser synthesis and nanomaterials modeling. ⚑ Her roles span EU consortia, bilateral research alliances, and editorial boards, demonstrating her impact in shaping scientific discourse. πŸ“š She mentors PhD students and postdocs across Europe and Africa and actively participates in curriculum development and international schools. 🌐 Recognized as a top invited speaker and panel expert, she also contributes to evaluation committees like ANR, NSF, and ERC, influencing science policy and innovation worldwide. πŸ†πŸ§¬

Research Focus πŸ”πŸ€–

Dr. Itina’s research primarily focuses on laser-induced nanomaterial synthesis and modeling. πŸ’₯ Her work delves into femtosecond and picosecond laser interactions with matter, exploring ultrafast processes like melting, ablation, and alloying. 🧫 She specializes in designing multifunctional nanohybrids, controlling surface wettability, and understanding nanoparticle transformations. 🌑️ With atomistic simulations and machine learning, she pioneers predictive approaches to optimize laser processing and material performance. πŸ€– Her findings advance applications in biomedicine, photonics, catalysis, and energy. 🌍 From theoretical frameworks to real-world innovations, Dr. Itina’s interdisciplinary research bridges physics, chemistry, and engineering in transformative ways. πŸ”§πŸ§ͺ

Awards and Honors πŸ†πŸŽ–οΈ

  • πŸ₯‡ IAAM Fellow Medal – International Association of Advanced Materials (2024)

  • πŸ† Outstanding Referee Award – Springer-Nature Journals

  • 🎀 Top Invited Speaker – SPIE Photonics West, HPLA, ICPEPA, SMS, LPHYS

  • πŸ‘©β€πŸ’Ό Scientific Board Member – SPIE, ALT, CECAM, E-MRS, Photonics West LASE

  • πŸ”¬ Founder – LASERMODE & PREDICT Research Teams (CNRS-recognized)

Publications & Citations πŸ“š

  1. πŸ“„ Investigation of nanoparticle generation during femtosecond laser ablation of metals (2007) – Cited by 1,000+ πŸ“ˆ
    πŸ”— Applied Surface Science

  2. πŸ“„ Spontaneous periodic ordering on the surface and in the bulk of dielectrics irradiated by ultrafast laser: a shared electromagnetic origin (2017) – Cited by 200+ πŸ“ˆ
    πŸ”— Scientific Reports

  3. πŸ“„ On nanoparticle formation by laser ablation in liquids (2010) – Cited by 500+ πŸ“ˆ
    πŸ”— The Journal of Physical Chemistry C

  4. πŸ“„ Understanding mono- and bi-metallic Au and Ni nanoparticle responses to fast heating (2024) – Cited by 50+ πŸ“ˆ
    πŸ”— Nanoscale Advances

  5. πŸ“„ Mechanisms of laser-based synthesis and modifications of nanomaterials (2023) – Cited by 100+ πŸ“ˆ
    πŸ”— SPIE Proceedings

πŸ” Conclusion:

Dr. Itina’s groundbreaking contributions, sustained research excellence, and scientific leadership make her an outstanding candidate for the Best Researcher Award. Her innovative modeling work and global impact align perfectly with the values this award aims to celebrate. She not only advances science but also empowers the next generation of researchers. πŸ…πŸ”

 

 

Florentina Lupascu | polymer nanoparticles | Best Paper Award

Published on by Chemical Scientist

Dr. Florentina Lupascu | polymer nanoparticles | Best Paper Award

University of Medicine and Pharmacy Grigore T Popa Iasi , Romania.

Florentina Geanina LupaΘ™cu πŸŽ“ is a dedicated Lecturer PhD in Pharmaceutical Chemistry at the University of Medicine and Pharmacy “Grigore T. Popa” IaΘ™i, Romania πŸ‡·πŸ‡΄. With expertise in pharmaceutical sciences, she has led innovative research in drug delivery systems, especially using polymers and nanoparticles πŸ’ŠπŸ”¬. A passionate mentor, she has coordinated numerous student theses and contributed extensively to the academic community through international collaborations 🌍, impactful publications πŸ“š, and scientific events. Her work has been recognized with prestigious awards πŸ… and editorial roles, showcasing her commitment to pharmaceutical advancement and professional excellence 🌟.

PROFILEΒ 

GOOGLE SCHOLARΒ 

 

πŸ” Summary of Suitability:

Dr. LupaΘ™cu has consistently contributed to the field of pharmaceutical sciences through original, high-impact research. Her publications include 37 full articles, 24 in ISI journals, and multiple authored books πŸ“˜. She has led a key project on pioglitazone-curcumin-loaded chitosan nanoparticles, a novel drug delivery system targeting Type 2 diabetes mellitus – an area of urgent global healthcare need 🌍. Her H-index (up to 11) and over 500 citations across platforms demonstrate significant scholarly influence πŸ“Š.

πŸŽ“ Education & ExperienceΒ 

πŸŽ“ Education:

  • πŸ§ͺ Bachelor of Pharmacy, UMF “Grigore T. Popa” IaΘ™i (2004–2009)

  • 🧬 PhD in Pharmaceutical Chemistry, UMF “Grigore T. Popa” IaΘ™i (2009–2013)

  • πŸ’Š Residency in Pharmaceutical Laboratory (2015–2019)

  • πŸ’Ό Residency in General Pharmacy (2020–2023)

πŸ§‘β€πŸ« Experience:

  • πŸ‘©β€πŸ« Assistant, UMF IaΘ™i – Faculty of Pharmacy (2013–2016)

  • πŸ‘©β€πŸ”¬ Lecturer, Pharmaceutical Chemistry (2016–present)

  • πŸ“š Scientific Coordinator – 40 graduation theses

  • πŸ‘₯ Guidance Committee – 3 PhD students

  • 🌐 Specializations abroad:

    • University of Ghent πŸ‡§πŸ‡ͺ (2012)

    • FIT 4-NANO Workshop, Lisbon πŸ‡΅πŸ‡Ή (2023)

Professional Development πŸš€πŸ“–

Dr. LupaΘ™cu is actively involved in enhancing her scientific and academic profile through international research networks 🌐, professional societies, and specialized workshops πŸ§‘β€πŸ”¬. She is a steering committee member in the COST Action CA19140 – Focused Ion Technology for Nanomaterials βš›οΈ and contributes to the advancement of pharmaceutical chemistry via roles in scientific societies and editorial boards πŸ“–. Her participation in national and international conferences, editorial projects (e.g., Polymers, Pharmaceutics journals) ✍️, and training programs such as drug administration techniques in animal models 🐁 highlights her dynamic engagement with cutting-edge pharmaceutical research and innovation πŸ’‘.

Research Focus πŸ”πŸ€–

Dr. LupaΘ™cu’s research centers around innovative drug delivery systems, particularly those targeting type 2 diabetes mellitus therapy using biopolymer-based nanoparticles like chitosan πŸ’ŠπŸŒΏ. She has explored the synergy between active pharmaceutical ingredients such as pioglitazone and curcumin, embedded within polymer matrices to enhance therapeutic effects πŸ“ˆ. Her interest lies in optimizing the pharmacological profile of oral antidiabetic agents via nanotechnological approaches 🧫. Active in interdisciplinary and translational research, she merges pharmaceutical chemistry, materials science, and nanomedicine πŸ§ͺπŸ”. Her work contributes to developing smarter, safer, and more effective drug systems for chronic diseases 🌑️.

Awards and Honors πŸ†πŸŽ–οΈ

  • πŸ† Best Paper Award – International Conference on Chemistry in Nanosciences and Biomaterials Engineering (June 2022)

  • πŸ₯‡ Best Oral Presentation – International Conference on Chemistry in Nanosciences and Biomaterials Engineering (June 2021)

  • πŸŽ–οΈ Originality of Results Award – Romanian National Pharmacy Congress, 16th Edition (October 2016)

Publications & Citations πŸ“š

  • πŸ“„ An overview of biopolymeric electrospun nanofibers based on polysaccharides for wound healing management πŸ“… 2020 πŸ“Š Cited by 160

  • πŸ“„ Recent biomedical approaches for chitosan based materials as drug delivery nanocarriers πŸ“… 2021 πŸ“Š Cited by 94

  • πŸ“„ The synthesis and the biological evaluation of new thiazolidin-4-one derivatives containing a xanthine moiety πŸ“… 2013 πŸ“Š Cited by 40

  • πŸ“„ New theophylline derivatives with potential pharmacological activity πŸ“… 2010 πŸ“Š Cited by 34

  • πŸ“„ Synthesis and biological evaluation of the new 1,3-dimethylxanthine derivatives with thiazolidine-4-one scaffold πŸ“… 2017 πŸ“Š Cited by 29

  • πŸ“„ Development and characterization of novel films based on sulfonamide-chitosan derivatives for potential wound dressing πŸ“… 2015 πŸ“Š Cited by 28

  • πŸ“„ New ibuprofen derivatives with thiazolidine-4-one scaffold with improved pharmaco-toxicological profile πŸ“… 2021 πŸ“Š Cited by 18

  • πŸ“„ The influence of a new rutin derivative on homocysteine, cholesterol and total antioxidative status in experimental diabetes in rat πŸ“… 2013 πŸ“Š Cited by 17

  • πŸ“„ The influence of a new rutin derivative in an experimental model of induced hyperhomocysteinemia in rats πŸ“… 2017 πŸ“Š Cited by 16

  • πŸ“„ Synthesis and biological evaluation of some new rutin semisynthetic derivatives as antibacterial agents πŸ“… 2012 πŸ“Š Cited by 11

  • πŸ“„ New derivatives of aryl-propionic acid. Synthesis and biological evaluation πŸ“… 2013 πŸ“Š Cited by 6

  • πŸ“„ New hydrazones with pyrazolone structure: synthesis, characterization and biological evaluation πŸ“… 2013 πŸ“Š Cited by 6

πŸ” Conclusion:

Given her pioneering work in nanomedicine, consistent scientific productivity, and prior accolades, Dr. Florentina LupaΘ™cu exemplifies the qualities of a Best Paper Award recipient. Her research offers both academic value and real-world therapeutic potential, making her a standout candidate for further recognition πŸ₯‡.

 

 

Jared Fischer | Nanotechnology | Best Researcher Award

Published on by Chemical Scientist

Dr. Jared Fischer | Nanotechnology | Best Researcher Award

Assistant Professor at Oregon Health and Science University , United States.

Dr. Jared Fischer 🧬 is an Assistant Professor at the Oregon Health & Science University (OHSU) in the Department of Molecular and Medical Genetics/CEDAR πŸ§‘β€πŸ«. With a dual degree in Zoology and Chemistry πŸ§ͺ from Miami University and a PhD in Molecular Genetics 🧫 from the University of Cincinnati, he has cultivated a rich career in cancer biology, senescence, and in vivo imaging. His innovative work in nanomedicine, cancer detection, and senolytic therapies has led to numerous high-impact publications and grants. Dr. Fischer is not only a prolific researcher πŸ“š but also a committed educator and mentor to future scientists πŸ‘¨β€πŸ”¬.

PROFILEΒ 

GOOGLE SCHOLARΒ 

SCOPUSΒ 

ORCIDΒ 

πŸ” Summary of Suitability:

Dr. Jared Fischer is an outstanding biomedical scientist and faculty member at Oregon Health & Science University (OHSU), serving as Assistant Professor in the Department of Molecular and Medical Genetics/CEDAR. His research career exemplifies consistent innovation, high-impact scholarship, and a commitment to translational medicine. His work spans multiple disciplines, including molecular genetics, cancer biology, nanomedicine, and biomedical imaging. Dr. Fischer has secured prestigious federal and institutional grants and consistently publishes in top-tier journals. Moreover, he has demonstrated exemplary service through education, mentorship, and committee leadershipβ€”solidifying his role as a leader and innovator in the research community.

πŸŽ“ Education and Experience

πŸŽ“ Education:

  • πŸ§ͺ BS in Zoology & BA in Chemistry, Miami University (1999–2003)

  • 🧬 PhD in Molecular Genetics, University of Cincinnati (2003–2008)

  • πŸ”¬ Postdoctoral Fellowship in Molecular and Medical Genetics, OHSU (2009–2017)

🏒 Academic Experience:

  • πŸ‘¨β€πŸ« Assistant Professor, OHSU, Molecular & Medical Genetics (2017–Present)

Professional Development πŸš€πŸ“–

Dr. Fischer’s professional growth is rooted in continuous learning, leadership, and service πŸ“ˆ. He completed the Leadership Development Course from Brave Heart Consulting in 2024 🧠 and was certified by the Mentorship Academy in 2023. Actively involved in mentoring underrepresented students πŸ‘¨β€πŸŽ“, he has contributed to cancer education through programs like the CURE Program and the Partnership for Scientific Inquiry πŸ”. As IACUC vice-chair and editorial reviewer ✍️, his institutional service has significantly impacted research governance and publication. His commitment to advancing scientific education, ethics, and community health underscores his dynamic and evolving career 🎯.

Research Focus πŸ”πŸ€–

Dr. Fischer’s research centers on cancer biology 🧫, senescence πŸ§“, and molecular imaging 🧲, particularly through nanomedicine and bioengineering innovations. His work targets early cancer detection πŸ§β€βš•οΈ, tumor progression 🧬, and therapeutic development using multifunctional nanomaterials and senolytic peptides πŸ’Š. He is known for pioneering diagnostic assays and nanoparticle-based imaging techniques πŸ§ͺ, as demonstrated in his recent publications on pancreatic and colorectal cancers. His interdisciplinary focus bridges molecular genetics, biomedical imaging, and computational modeling 🧠, aligning with cutting-edge research in oncology and personalized medicine πŸ§‘β€βš•οΈ. His contributions are shaping next-generation strategies in precision diagnostics and therapeutic delivery πŸš€.

Awards and Honors πŸ†πŸŽ–οΈ

  • 🧾 OHSU β€œPaper of the Month” for PNAS publication, December 2016

  • πŸ§‘β€πŸŽ“ Graduate Student of the Year, University of Cincinnati, Department of Molecular Genetics, 2008

  • 🎀 Invited Speaker at Cambridge University, Cold Spring Harbor, and various ACS events

  • πŸŽ—οΈ Recognized across high-profile media (Nature, Science News, Forbes, JAMA) for breakthrough cancer diagnostics research

Publications & Citations πŸ“š

πŸ“˜ 2025

  • 🧬 Early detection of pancreatic cancer by protease-activated nanosensor assay – Published in Science Translational Medicine, featured in Nature, Science News, Forbes πŸ“ˆ

πŸ“— 2024

  • πŸ§ͺ Profiling protease cleavage in plasma for pancreatic cancer – Published in Scientific Reports

  • 🧫 Tumor-immune hybrid cells and colorectal cancer metastasis via CTLA4 – Published in Clinical and Experimental Medicine

πŸ“™ 2023

  • πŸ’‘ Ultrafast ultrasound imaging using blinking nanoparticles – Published in Nano Letters

  • 🧬 Gas-stabilizing nanoparticles for cancer therapy – Published in Advanced Materials Interfaces

πŸ“— 2022

  • βš—οΈ Hybrid PLGA nanoparticles for enzyme therapy – Published in Pharmaceutics

  • πŸ”¬ Computational design of TP63-TP53 inhibitors – Published in Molecular Cancer Therapeutics

πŸ“˜ 2021

  • 🧠 Modeling FOXO4-TP53 to create senolytic peptides – Published in EBioMedicine

  • πŸ” Label-free enrichment of rare neoplastic cells using microfluidics – Published in Communications Biology

πŸ“• 2020

  • πŸ“Š Weight loss, biomarkers & cancer risk – Published in Surg Obes Relat Dis

πŸ“˜ 2019

  • 🧫 Silica cloaking of adenovirus for gene delivery – Published in Journal of Controlled Release

πŸ“™ 2018

  • 🧬 Cell fusion and hybrid circulating tumor cells – Published in Science Advances, highly cited and shared πŸ“ˆ

πŸ“— 2017

  • 🧬 Genetic divergence in tumor evolution – Published in Nature Genetics, highly cited and impactful πŸ“ˆ

πŸ“• 2016

  • 🧬 TgfΞ²R2 in intestinal stem cells – Published in PNAS, earned “Paper of the Month” at OHSU πŸ†

  • πŸ§ͺ Pms2 ATPase domain study – Published in DNA Repair

πŸ“˜ 2014

  • 🧬 Apc-deficient crypts and chemoprevention – Published in Carcinogenesis

πŸ“• 2012

  • 🧬 Phenotypic outcomes of Apc loss – Published in Oncogene

πŸ“™ 2008–2006 (select highlights)

  • 🧬 Mutation in aging mice – Published in Aging Cell

  • πŸ” Loss of heterozygosity in mouse tissues – Published in Mutation Research

  • 🧫 Co-mutagenic effects of arsenic and benzo[a]pyrene – Published in Mutation Research

πŸ“— 2004–2003

  • 🧬 Evolution of Pneumocystis species – Published in Microbiology & J Eukaryotic Microbiology

πŸ” Conclusion:

Dr. Jared Fischer is a truly deserving nominee for the Best Researcher Award. His body of work demonstrates not only scientific rigor and innovation but also a profound impact on patient care, early disease detection, and therapeutic development. His interdisciplinary approach, dedication to mentoring, and consistent scholarly output position him among the top-tier researchers advancing modern medicine today.